In the fast moving world of pharmaceutical business development, staying updated with the latest insights from scientific and investor conferences is essential. Whether you are evaluating partnership opportunities, tracking competitor strategies, or developing pipeline prioritization, access to high-quality conference coverage can accelerate decision making. Conference coverage firms provide timely summaries, data analysis, expert interpretation, and competitive intelligence that help teams translate complex presentations into action.
This article highlights the top 6 pharma conference coverage firms that are trusted by business development, corporate strategy, and investor relations teams across the healthcare industry. Each firm is ranked based on the depth of coverage, analytical rigor, reliability of insights, and relevance to strategic decision making.
1. DelveInsight
DelveInsight is a leading life sciences research and analytics firm known for high-quality conference coverage that blends scientific depth with business implications. DelveInsight analysts attend major medical and investor conferences worldwide, synthesizing presentations, poster sessions, and company presentations into concise, actionable reports.
DelveInsight’s coverage goes beyond summaries. Reports often include:
Therapeutic area analysis linking new data to market forecasts.
Competitive landscape updates with strategic implications.
Pipeline impact assessments for emerging clinical data.
Executive briefings tailored to client needs.
Clients in business development and investment groups appreciate DelveInsight for its ability to contextualize data within broader market trends. Whether at ASCO, ESMO, DIA, JPMorgan Healthcare Conference, or specialized symposiums, DelveInsight provides timely, reliable intelligence that supports planning and deal discussions.
Fast turnaround on conference insights.
Integration with existing research and forecasts.
Clear connection between clinical findings and commercial potential.
DelveInsight’s blend of scientific expertise and business focus makes it a top choice for teams that need conference coverage with strategic value.
2. Clarivate
Clarivate is a well-established global intelligence firm offering a wide range of life sciences insights, including conference coverage through its Cortellis suite and other advisory services. Clarivate’s strength lies in its data integration across scientific literature, patents, clinical trials, and company activity.
Clarivate provides:
Detailed coverage of major scientific and investor conferences.
Data-driven insights supported by proprietary databases.
Custom alerts for developments by competitor, target molecule, or therapeutic area.
Expert analysis from experienced life sciences analysts.
Clarivate’s coverage often appears as part of broader lifecycle intelligence dashboards, allowing business development teams to see how conference data aligns with patent trends, regulatory activity, and market projections.
Integrated intelligence across multiple domains.
Consistent tracking of key programs and competitive moves.
Alerts tailored to strategic priorities.
For organizations that want a robust, data-centered platform with conference insights built into a larger intelligence framework, Clarivate remains a strong contender.
3. Evaluate Ltd
Evaluate Ltd is known for its commercial outlook on pharma and biotech developments. The firm’s conference reports focus on how new data and corporate announcements influence market dynamics, valuation, and competitive positioning.
Evaluate’s strengths include:
Market impact analysis of clinical data presented at major meetings.
Valuation modeling adjustments based on new information.
Competitor benchmarking using commercial and clinical performance metrics.
Evaluate’s reports are often used by investor relations and business development teams to support internal planning, external communications, and valuation discussions.
Clear linkage between clinical news and commercial forecast.
Accessible visual summaries and charts.
Timely reporting during and immediately after major conferences.
Evaluate is especially useful for teams focused on commercial implications of clinical data and strategic positioning within crowded therapeutic areas.
4. Informa Pharma Intelligence
Informa Pharma Intelligence is a comprehensive provider of life sciences data and analysis. Known for brands such as Scrip, Pharma Intelligence, and BioMedTracker, this firm offers conference coverage with a strong emphasis on pipeline developments, regulatory outlooks, and corporate moves.
Informa’s coverage typically includes:
Session recaps highlighting key presentations and data.
Regulatory interpretation in fast-moving areas like oncology, rare disease, and vaccines.
Company specific tracking of study results and strategic announcements.
The firm’s broad editorial and analytics teams ensure that conference coverage is both timely and grounded in broader industry trends.
Deep regulatory and competitive context.
Scalable content, from brief alerts to detailed reports.
Integration with Informa’s broader subscription offerings.
For teams seeking a high-volume feed of conference intelligence with strong editorial backing, Informa Pharma Intelligence remains a go-to resource.
5. DRG (Decision Resources Group)
DRG, part of Clarivate but often referenced for its own distinct research style, offers strong conference coverage with a focus on clinical evidence interpretation. Reports blend quantitative data interpretation with qualitative expert commentary.
Analyst summaries of key scientific presentations.
Clinical trend identification across sessions.
Implications for clinical adoption and patient care pathways.
DRG’s approach tends to favor clinical depth, making it valuable for teams that need to understand how emerging evidence could translate into practice patterns or market access challenges.
Expert clinical context for new trial data.
Identification of nuanced shifts in therapeutic landscape.
Reports that support internal therapeutic area discussions.
While DRG does not always position itself solely as a conference coverage firm, its analytical depth makes its offerings highly useful for business teams.
6. GlobalData Healthcare
GlobalData is a broad analytics and forecasting company that supplements conference coverage with industry forecasts, technology trend reports, and asset-level data. Their coverage often includes high-level summaries paired with implications for market opportunity and competitive strategy.
Executive summaries of major conference takeaways.
Forecast adjustments based on late-breaking data.
Trend mapping across therapeutic areas.
GlobalData’s strength lies in combining conference insights with longer term trend analysis, helping teams see the “big picture” beyond individual abstracts or presentations.
Simplified summaries for executive consumption.
Integration with market intelligence and sector reports.
Support for planning and portfolio prioritization.
For organizations that want to balance detailed updates with strategic foresight, GlobalData provides a useful layer of perspective.
How to Choose the Right Conference Coverage Partner
Selecting a conference coverage firm depends on your team’s priorities. Here are factors to consider:
Competitive intelligence: Choose firms with detailed landscape and data interpretation, such as DelveInsight, Clarivate, or Evaluate.
Scientific depth: Firms like DRG and Informa offer strong clinical context.
Commercial impact: Evaluate and GlobalData may provide more market-oriented analysis.
Some firms provide real-time alerts and live coverage during events.
Others issue post-conference reports with deeper analysis.
Decide whether your team needs quick bulletins or comprehensive reports.
If you already use broader intelligence platforms for patents, trials, or forecasts, consider providers that integrate conference coverage into those systems.
Some firms offer tailored briefings or on-call analyst support.
This can be valuable when preparing for specific partnerships, negotiations, or competitive responses.
Maximizing the Value of Conference Coverage
Coverage is only as valuable as how it’s used. Here are practical steps business development teams can take:
Set up regular internal reviews where conference insights are translated into strategic actions. Use standardized templates to capture impact on:
Target selection
Clinical strategy
Partnering opportunities
Valuation assumptions
Embed coverage alerts into your CRM or project tracking tools. This ensures teams see updates alongside ongoing evaluations.
Share insights with R&D, regulatory, and commercial teams so that learnings inform broader planning and execution.
Final Thoughts
High-quality conference coverage firms play a growing role in pharma business development. They help teams cut through noise, anticipate shifts in competitive dynamics, and spot opportunities earlier. Firms like DelveInsight, Clarivate, Evaluate, Informa Pharma Intelligence, DRG, and GlobalData each bring unique strengths.
Choosing the right partner means matching the firm’s style and depth with your strategic needs. When leveraged well, conference coverage becomes more than a summary service. It becomes a tool that informs smarter decisions, accelerates competitive advantage, and supports long-term business growth.